Novartis | NOVN - Trade Creditors

Stock Price
120.30
Daily Change
1.02 0.86%
Monthly
5.90%
Yearly
24.24%
Q1 Forecast
111.83

Novartis reported $4.56B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Alcon AG USD 895M 0 Sep/2025
Almirall EUR 199.39M 50.03M Jun/2025
Amgen USD 19.64B 1.61B Sep/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
Autolus Therapeutics Ltd USD 10.97M 5.56M Sep/2025
Bayer EUR 6.38B 343M Sep/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Fresenius EUR 1.08B 65M Sep/2025
Fresenius Medical Care EUR 725.85M 25.9M Sep/2025
Galapagos EUR 100.63M 32.55M Sep/2025
Genmab DKK 6M 2M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
GRIFOLS EUR 878.68M 26.38M Jun/2025
Hikma Pharmaceutical USD 611M 253M Jun/2025
J&J USD 9.62B 161M Sep/2025
Lonza CHF 471M 3M Dec/2024
Merck EUR 1.93B 32M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Orion EUR 87.6M 1.5M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Philips EUR 1.71B 39M Sep/2025
Recordati EUR 315.05M 15.17M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 3.29B 2.54B Jun/2025